Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 265-271

  Chaaitanya, Itta Krishna ^a   Muruganandam, Nagarajan ^a   Sundaram, Senthil G ^a   Kawalekar, Omkar ^b   Sugunan, Attayur P ^a   Manimunda, Sathya P ^a   Ghosal, Sruti R ^a   Muthumani, Karuppiah ^b   Vijayachari, Paluru ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTHROPATHY; ARTICLE; BLOOD SAMPLING; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CHIKUNGUNYA VIRUS ARTHRITIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INDIA; POLYARTHRITIS; RHEUMATOID ARTHRITIS; ROSS RIVER ALPHA VIRUS; SERUM;

ADULT; ALPHAVIRUS INFECTIONS; ARTHRITIS, INFECTIOUS; CHIKUNGUNYA VIRUS; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MIDDLE AGED;

CHIKUNGUNYA VIRUS; ROSS RIVER VIRUS;

EID: 80051719278     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0123     Document Type: Article

References (44)

1. AbuBakar S, Sam IC, Wong PF, et al.: Re-emergence of endemic Chikungunya, Malaysia. Emerg Infect Dis 2007;13: 147-149.
2. Bai F, Town T, Qian F, Wang P, et al.: IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 2009;5:10.
3. Borgherini G, Poubeau P, Staikowsky F, et al.: Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007;44: 1401-1407. (Pubitemid 46801580)
4. Lidbury BA, and Mahalingam S: A role for chemokine activity in Alphavirus pathogenesis: Evidence from the analysis of polyarthritis and myalgia post-Ross river virus infection. NCBI Book shelf, Madame Curie Bioscience database, 2000.
5. Brighton SW: Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S Afr Med J 1984;11:217-218. (Pubitemid 14063933)
6. Chatterjee SN, Chakravarti SK, Mitra AC, and Sarkar JK: Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta. J Indian Med Assoc 1965;45:314-316.
7. Couderc T, Chrétien F, Schilte C, et al.: A mouse model for chikungunya: Young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008;4:29.
8. Ellis M, al-Ramadi B, Hedstrom U, et al.: Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study. Br J Haematol 2005;128:482-489. (Pubitemid 40283164)
9. Enserink M: Tropical disease follows mosquitoes to Europe. Science 2007;317:1485. (Pubitemid 47417406)
10. Gérardin P, Guernier V, Perrau J, et al.: Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 2008;28:99.
11. Hundekar SL, Thakare JP, Gokhale MD, et al.: Development of monoclonal antibody based antigen capture ELISA to detect chikungunya virus antigen in mosquitoes. Indian J Med Res 2002;115:144-148. (Pubitemid 35021346)
12. John CC, Opika-Opoka R, Byarugaba J, et al.: Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis 2006;194:837-845. (Pubitemid 44344133)
13. Kaneko S, Satoh T, Chiba J, et al.: Interleukin-6 and interleukin- 8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-79.
14. Keystone EC: Abandoned therapies and unpublished trials in rheumatoid arthritis. Curr Opin Rheumatol. 2003;15: 253-258. (Pubitemid 36532605)
15. Krishnamoorthy K, Harichandrakumar KT, Kumari AK, and Das LK: Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. J Vector Borne Dis 2009;46:26-35.
16. Labadie K, Larcher T, Joubert C, et al.: Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010;120:894-906.
17. Lee N, Wong CK, Lam WY, et al.: Chikungunya fever, Hong Kong. Emerg Infect Dis 2006;12:1790-1792.
18. Liu MT, Armstrong D, Hamilton TA, and Lane TE: Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 2001;166:1790-1795. (Pubitemid 32114664)
19. Macias MP, Fitzpatrick LA, Brenneise I, et al.: Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest 2001;107: 949-959. (Pubitemid 32323405)
20. Malemud CJ: Focus on pain mechanisms and pharmacy therapy in the treatment of fibromyalgia syndrome. Clin Exp Rheumatol 2009;27:86-91.
21. Manimunda SP, Sugunan AP, Rai SK, et al.: Outbreak of chikungunya fever, Dakshina Kannada district, South India. American J Trop Med Hyg 2010;83:751-754.
22. Manimunda SP, Vijayachari P, Uppoor R, et al.: Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010;104: 392-399.
23. Mateo L, La Linn M, Mc Coll SR, et al.: An arthrogenic alphavirus induces monocytes chemoattractant protein 1 and interleukin 8. Intervirology 2000;43:55-60. (Pubitemid 30206810)
24. Morrison TE, Whitmore AC, Shabman RS, et al.: Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006;80:737-749. (Pubitemid 43062886)
25. National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India: Chikungunya situation in India. 2009. Available at chikun-update07.pdf. Accessed April 17, 2010.
26. Ng LFP, Chow A, Sun Y-J, et al.: IL-1b, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS ONE 2009;4: 4261.
27. Orhan Sezer: Myeloma bone disease. Haematology 2005;10: 19-24.
28. Ozden S, Huerre M, Riviere J-P, et al.: Human muscle satellite cells as targets of Chikungunya virus infection. PLoS ONE 2007;2:e527.
29. Palacios I, Lopez-Armada MJ, Hernandez P, et al.: Tenidap decreases IL-8 and monocytes chemoactive peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbit with antigen arthritis and in cultured synovial cells. Clin Exp Immunol 1998;111:588-596. (Pubitemid 28160906)
30. Petersen AM, and Pedersen BK: The anti- inflammatory effect of exercise Review. J Appl Physiol 2005;98:1154-1162. (Pubitemid 40396484)
31. Pialoux G, Gauzere BA, Jaureguiberry S, and Storbel M: Chikungunya, an epidemic arbovirosis. Lancet 2007;319-327. (Pubitemid 46613868)
32. Powers AM, and Logue CH: Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007;88:2363-2377. (Pubitemid 47323881)
33. Ravi V Re-emergence of chikungunya virus in India Indian J. Med. Microbiol. 2006;24:83.
34. Robinson MC: An epidemic of virus disease in southern province, Tanganyika Territory, in 1952-53. I Clinical features Trans R Soc Trop Med Hyg 1955;49:28-32.
35. Rubin LA, Kurman CC, Fritz ME, et al.: Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-3177. (Pubitemid 16250575)
36. Sissoko D, Malvy D, Ezzedine K, et al.: Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 2009;3:389.
37. Sourisseau M, Schilte C, Casartelli N, et al.: Characterization of reemerging Chikungunya virus. PLoS Pathog 2007;3:89.
38. Stankovic A, Slavic V, Stamenkovic B, et al.: Serum and synovial fluid concentration of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy 2009;110:641-646.
39. Higgs S, and Ziegler SA: A nonhuman primate model of chikungunya disease. J Clin Invest 2010;120;657.
40. Thiboutot MM, Kannan S, Kawalekar OU, et al.: Chikungunya: a potentially emerging epidemic? PLoS Negl Trop Dis 2010;27:623.
41. Toh K, Kukita T, Wu Z, et al.: Possible involvement of MIP- 1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis. Lab Invest 2004;84:1092-1102. (Pubitemid 39128255)
42. Van Damme J, Proost P, Put W, et al.: Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol 1994;152:5495-5502. (Pubitemid 24152999)
43. Yasukawa H, Ohishi M, Mori H, et al.: IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunol 2003;4:551-556. (Pubitemid 36701338)
44. Yergolkar PN, Tandale BV, Arankalle VA, et al.: Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis 2006;12:1580-1583. (Pubitemid 44570904)